$47.36 -1.07 (%) Mylan Inc - NASDAQ

Sep. 19, 2014 | 04:00 PM

Partner Headlines

  1. Gilead to license Sovaldi

    IBD | Sep. 15, 2014 | 18:53PM EST
  2. Gilead OKs Generic Sovaldi To Expand Global Access

    IBD | Sep. 15, 2014 | 11:35AM EST
  3. US Stock Futures Down Ahead Of Industrial Production Report

    Benzinga | Sep. 15, 2014 | 07:13AM EST
  4. Mylan In Pact With Gilead To Accelerate Access To Hepatitis C

    Benzinga | Sep. 15, 2014 | 06:31AM EST
  5. Corporate Tax Cuts Would Help Treasury And Investors

    IBD | Sep. 11, 2014 | 18:04PM EST
  6. Mylan to Acquire U.S. Rights to Arixtra Injection From Aspen

    Benzinga | Sep. 10, 2014 | 07:02AM EST
  7. Court Grants Summary Judgment In Favor Of Mylan And FDA Related To Generic

    Benzinga | Sep. 8, 2014 | 07:02AM EST
  8. Why Burger King Isn't Like Walgreen In Tax Inversions

    IBD | Aug. 25, 2014 | 13:23PM EST
  9. Benzinga's Top Downgrades

    Benzinga | Aug. 8, 2014 | 09:04AM EST
  10. US Stock Futures Edge Higher Ahead Of Productivity Data

    Benzinga | Aug. 8, 2014 | 07:41AM EST
  11. RBC Capital Downgrades Mylan To Sector Perform

    Benzinga | Aug. 8, 2014 | 07:10AM EST
  12. Salix Q2 Misses Estimates; Novo Nordisk, Mylan Slide

    IBD | Aug. 7, 2014 | 18:50PM EST
  13. Mylan shares down on Q2 miss

    IBD | Aug. 7, 2014 | 18:41PM EST
  14. S&P 500 Falls To Two-Month Low, Dow Drifts Further Away From The 17,000 Mark

    Benzinga | Aug. 7, 2014 | 16:41PM EST
  15. Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats

    IBD | Aug. 7, 2014 | 12:04PM EST
  16. US Stock Futures Rise; Jobless Claims Report In Focus

    Benzinga | Aug. 7, 2014 | 07:44AM EST
  17. UPDATE: Mylan Posts Lower Q2 Earnings, Narrows Full-Year Outlook

    Benzinga | Aug. 7, 2014 | 07:17AM EST
  18. Walgreen Seen Rejecting Tax Inversion Amid Pressure

    IBD | Aug. 5, 2014 | 15:26PM EST
  19. Walgreen Names New CFO Ahead of Possible Inversion

    IBD | Aug. 4, 2014 | 12:29PM EST
  20. 5 Drug Companies Profiting From Generics

    Benzinga | Aug. 4, 2014 | 08:29AM EST
  21. Salix, Actavis Lead IBD 50 Drug Earnings This Week

    IBD | Aug. 2, 2014 | 08:02AM EST
  22. How Obama Could End Walgreen's Tax-Inversion Hopes

    IBD | Jul. 28, 2014 | 14:41PM EST
  23. Mylan Wins Motion For Temporary Restraining Order Against Apotex For Authorized Generic Of Paxil CR

    Benzinga | Jul. 23, 2014 | 07:08AM EST
  24. Will Congress Scuttle the AbbVie-Shire Merger?

    FoxBusiness | Jul. 18, 2014 | 13:23PM EST
  25. Mylan Wins Motion To Enjoin GlaxoSmithKline From Providing Paroxetine CR Yo Apotex; Apotex Can No Longer Supply Authorized Generic Product

    Benzinga | Jul. 17, 2014 | 07:02AM EST
  26. Abbott, St. Jude Top Views, But Stocks Under Pressure

    IBD | Jul. 16, 2014 | 18:10PM EST
  27. Treasury Urges Halt to Tax Inversion M&A 'Abuse'

    IBD | Jul. 16, 2014 | 15:28PM EST
  28. UPDATE: Bank Of America Reiterates On Mylan Following Abbott Transaction

    Benzinga | Jul. 15, 2014 | 08:49AM EST
  29. AbbVie Near $54 Bil Shire Buy

    IBD | Jul. 14, 2014 | 18:49PM EST
  30. Mylan, AbbVie News Shows Tax Inversion Boom Continues

    IBD | Jul. 14, 2014 | 17:30PM EST
  31. Stocks Slip From Day's Highs; Kandi Zooms On Sales Report

    IBD | Jul. 14, 2014 | 13:25PM EST
  32. Mylan Buying Abbott Generics Unit, Moving Abroad

    IBD | Jul. 14, 2014 | 11:27AM EST
  33. Benzinga's Volume Movers

    Benzinga | Jul. 14, 2014 | 10:20AM EST
  34. Morning Market Movers

    Benzinga | Jul. 14, 2014 | 09:38AM EST
  35. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 14, 2014 | 08:10AM EST
  36. Novo, Other Medicals Display Healthy Action

    IBD | Jun. 26, 2014 | 18:41PM EST
  37. Generic-Drug Makers Climb Ranks; Several In Buy Range

    IBD | Jun. 20, 2014 | 18:12PM EST
  38. Wells Fargo Initiates Coverage On The Pharmaceutical Space

    Benzinga | Jun. 11, 2014 | 11:36AM EST
  39. Mylan

    IBD | May. 1, 2014 | 18:54PM EST
  40. Earnings Scheduled For May 1, 2014

    Benzinga | May. 1, 2014 | 05:36AM EST
  41. Forest Acquiring Furiex To Boost GI Franchise

    IBD | Apr. 28, 2014 | 13:00PM EST
  42. Stocks Open Up, Techs Stressed; March Pending Home Sales Soar

    IBD | Apr. 28, 2014 | 10:41AM EST
  43. Morning Market Losers

    Benzinga | Apr. 28, 2014 | 09:51AM EST
  44. Benzinga's Weekend M&A Chatter

    Benzinga | Apr. 27, 2014 | 20:21PM EST
  45. Indexes Near Session Lows As Tech Stocks Are Routed

    IBD | Apr. 25, 2014 | 14:58PM EST
  46. Mylan Raises Bid for Meda to 145 Kroner/Share, Shares Gain 3%

    Benzinga | Apr. 25, 2014 | 14:34PM EST
  47. Mylan Shares Spike Higher; Hearing Chatter of New Meda Bid

    Benzinga | Apr. 25, 2014 | 10:45AM EST
  48. Scott Black's Top First Quarter Holdings

    GuruFocus | Apr. 23, 2014 | 22:47PM EST
  49. UPDATE: Mylan Launches First Generic ORTHO EVRA Patch

    Benzinga | Apr. 16, 2014 | 16:14PM EST
  50. Mylan Launches Generic Lunesta Tablets

    Benzinga | Apr. 15, 2014 | 10:09AM EST
Trading Center